Literature DB >> 32413133

In Reply: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic.

Adroaldo Rossetti1, Davi Jorge Fontoura Solla2, Cristina Salles1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32413133      PMCID: PMC7239093          DOI: 10.1093/neuros/nyaa222

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


× No keyword cloud information.
To the Editor: The COVID-19 pandemic crisis has been defying health professionals and managers at all levels. Due to the risk of health system overload, there is an unpaired need to infrastructure, human, and economic resource allocation management. At a time when global attention is focused on the pandemic, we should not overlook that people continue to face other health problems. The incidents of trauma and accidental injury tend to decrease due to social distancing, quarantine, or locking. However, other diseases, such as stroke and neoplasms, inexorably follow their natural course. The correspondence published by Patel et al draws attention to the potential risks of endonasal endoscopic surgery in COVID-19 diagnosed or suspected patients and the need for surgical practice provisional update. Based on personal communication, it reports, in a narrative fashion, a series of cases of health worker contamination related to the care of patients undergoing endoscopic endonasal surgery despite the best efforts to perform a safe surgery. Similar incidents occurred in several reference services around the world. The authors emphasize the need for adequate use of personal protective equipment (PPE) in cases tested positive for COVID-19—although it questions the sensitivity and specificity of such tests—and recommend limiting the number of professionals during procedures only to the essential ones. Since the pandemic breakthrough in Wuhan, China, in December 2019, thousands of health workers have been infected during the care of patients with COVID-19. The high viral load in the upper airways of infected patients poses a greater risk during endoscopic endonasal procedures, especially when high-speed drilling is needed, which increases the production of aerosols and the suspension of viral particles in the environment. It is very clear within the neurosurgical community that protocols should be planned to determine which neurosurgical cases must be prioritized. Such protocols should consider the urgency status and type of the procedure, the need and length of postoperative intensive care support, and the preoperative testing of patients when possible. Burke et al and Ramakrishna et al demonstrate in a pragmatic way how to implement such stratification initiatives. Moreover, given the potential shortage of intensive care unit (ICU) and ward beds, there is an opportunity to foster the ongoing phenomenon of adoption of quality improvement programs such as the Enhanced Recovery After Surgery (ERAS). The ERAS implementation initiatives have shown improved patient outcomes while reducing length of stay and costs. Thus, the postponement of endoscopic endonasal neurosurgical procedures seems feasible and, in the current scenario, an appropriate solution.

Disclosures

The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.
  5 in total

1.  Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies.

Authors:  Alan D Workman; D Bradley Welling; Bob S Carter; William T Curry; Eric H Holbrook; Stacey T Gray; George A Scangas; Benjamin S Bleier
Journal:  Int Forum Allergy Rhinol       Date:  2020-05-22       Impact factor: 3.858

2.  Safety and efficacy of a novel neurosurgical enhanced recovery after surgery protocol for elective craniotomy: a prospective randomized controlled trial.

Authors:  Yuan Wang; Bolin Liu; Tianzhi Zhao; Binfang Zhao; Daihua Yu; Xue Jiang; Lin Ye; Lanfu Zhao; Wenhai Lv; Yufu Zhang; Tao Zheng; Yafei Xue; Lei Chen; Eric Sankey; Long Chen; Yingxi Wu; Mingjuan Li; Lin Ma; Zhengmin Li; Ruigang Li; Juan Li; Jing Yan; Shasha Wang; Hui Zhao; Xude Sun; Guodong Gao; Yan Qu; Shiming He
Journal:  J Neurosurg       Date:  2018-06-01       Impact factor: 5.115

3.  Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.

Authors:  Rohan Ramakrishna; Gelareh Zadeh; Jason P Sheehan; Manish K Aghi
Journal:  J Neurooncol       Date:  2020-04-09       Impact factor: 4.130

4.  Letter: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic.

Authors:  Zara M Patel; Juan Fernandez-Miranda; Peter H Hwang; Jayakar V Nayak; Robert Dodd; Hamed Sajjadi; Robert K Jackler
Journal:  Neurosurgery       Date:  2020-07-01       Impact factor: 4.654

5.  Letter: The Coronavirus Disease 2019 Global Pandemic: A Neurosurgical Treatment Algorithm.

Authors:  John F Burke; Andrew K Chan; Valli Mummaneni; Dean Chou; Errol P Lobo; Mitchel S Berger; Philip V Theodosopoulos; Praveen V Mummaneni
Journal:  Neurosurgery       Date:  2020-07-01       Impact factor: 4.654

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.